Transdisciplinarity in the approach to amyloidosis
DOI:
https://doi.org/10.31053/1853.0605.v78.n3.32341Keywords:
amyloidosys, salivary glands, biopsyAbstract
The increasing complexity in the approach to diseases challenges the development of a new paradigm of care that crosses disciplinary limits, where professionals from different disciplines approach a problem applying their expertise, respecting the knowledge of the other and contributing to the global view of the problem. Amyloidoses are rare diseases. The diagnosis is based on the biopsy of those organs in which amyloid infiltration is suspected. There is an increased risk of bleeding associated with these procedures. Therefore, the availability of obtaining samples from certain sites with less invasive accesses, such as the minor salivary glands (GSM), represent an alternative. Objectives: Describe the experiences of GSM biopsies as a diagnostic tool in the detection of amyloidosis and its intra and postoperative complications. - Estimate the diagnostic performance. The design is a cross-sectional cohort. All patients with a suspected diagnosis of amyloidosis were consecutively included, between August 2018-September 2020. Results: 23 biopsies were performed with minimally invasive procedures. 60.86% were male and the average age was 66 years. The prevalence of amyloidosis was 33%. The sensitivity was 55% and the specificity 100%. One patient had more bleeding than usual during the procedure and none had postoperative complications. Conclusions: GSM biopsy experiences were described as a diagnostic tool for amyloidosis, reporting a slight intraoperative complication and no postoperative complication. The test achieved a sensitivity of 55% and a specificity of 100%.
Downloads
References
Aguirre MA, Boietti BR, Nucifora E, Sorroche PB, González Bernaldo de Quirós F, Giunta DH, Posadas-Martínez ML. Incidence rate of amyloidosis in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Amyloid. 2016 Sep;23(3):184-187. doi: 10.1080/13506129.2016.1207626.
Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, Dungu J, Banypersad SM, Wechalekar AD, Whelan CJ, Hawkins PN, Gillmore JD. Systemic amyloidosis in England: an epidemiological study. Br J Haematol. 2013 May;161(4):525-32. doi: 10.1111/bjh.12286.
Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017 Jun 20;86:27-68. doi: 10.1146/annurev-biochem-061516-045115.
Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014 Dec;21(4):221-4. doi: 10.3109/13506129.2014.964858.
Lado Lado FL, Ferreiro Regueiro M J, Cabana González B, Díez Díez V, Maceda Vilariño S, Antúnez López J R. Amiloidosis. Medicina Integral 2000;137-141.
Bennhold H: Specific staining of amyloid by Congo red. Munch Med Wochenschr 1922; 69: 1537–1538.
Divry P, Florkin M: Sur les propriétés optiques de l’amyloide. Paris, CR Société de Biologie, 1927, pp 1808–1810.
Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002 Jun 6;346(23):1786-91. doi: 10.1056/NEJMoa013354.
Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381.
Soares SM, Fervenza FC, Lager DJ, Gertz MA, Cosio FG, Leung N. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis. 2008 Dec;52(6):1079-83. doi: 10.1053/j.ajkd.2008.05.022.
Lida Santiago M, Seisdedos MR, García Salinas RN, Secco A, Marino Claverie L, Techera L, Takashima L, Aicardi P, Sandi Rosales MA, Knobel E, Magri SJ, Catalán Pellet AC. Frequency of complications and usefulness of the minor salivary gland biopsy. Reumatol Clin. 2012 Sep-Oct;8(5):255-8. doi: 10.1016/j.reuma.2012.03.006.
Lecadet A, Bachmeyer C, Buob D, Cez A, Georgin-Lavialle S. Minor salivary gland biopsy is more effective than normal appearing skin biopsy for amyloid detection in systemic amyloidosis: A prospective monocentric study. Eur J Intern Med. 2018 Nov;57:e20-e21. doi: 10.1016/j.ejim.2018.07.026.
de Paula Eduardo F, de Mello Bezinelli L, de Carvalho DL, Della-Guardia B, de Almeida MD, Marins LV, Corrêa L. Minor salivary gland biopsy for the diagnosis of familial amyloid polyneuropathy. Neurol Sci. 2017 Feb;38(2):311-318. doi: 10.1007/s10072-016-2760-1.
Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki H, Iida S. Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. Ann Hematol. 2016 Jan;95(2):279-85. doi: 10.1007/s00277-015-2549-y.
Linke RP. Protein Misfolding, Aggregation, and Conformational Diseases. Boston: Springer; 2006. Chapter 1, Congo Red Staining of Amyloid: Improvements and Practical Guide for a More Precise Diagnosis of Amyloid and the Different Amyloidoses; p 239–276.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
